SELLAS Life Sciences Group, Inc.SLSNASDAQ
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank64
3Y CAGR+29.5%
5Y CAGR+46.7%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+29.5%/yr
vs -28.9%/yr prior
5Y CAGR
+46.7%/yr
Recent deceleration
Acceleration
+58.5pp
Accelerating
Percentile
P64
Within normal range
vs 5Y Ago
6.8x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$1.41M+123.3%
2024$632000.00+19.5%
2023$529000.00-18.5%
2022$649000.00-85.1%
2021$4.36M+1995.2%
2020$208000.00-68.9%
2019$668000.00-73.7%
2018$2.54M+132.6%
2017$-7.79M-251.8%
2016$5.13M-